{
    "Symbol": "PODD",
    "AssetType": "Common Stock",
    "Name": "Insulet Corporation",
    "Description": "Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.",
    "CIK": "1145197",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS",
    "Address": "9 OAK PARK DRIVE, BEDFORD, MA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "13759261000",
    "EBITDA": "339400000",
    "PERatio": "58.82",
    "PEGRatio": "3.561",
    "BookValue": "11.29",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "3.34",
    "RevenuePerShareTTM": "25.5",
    "ProfitMargin": "0.131",
    "OperatingMarginTTM": "0.129",
    "ReturnOnAssetsTTM": "0.0674",
    "ReturnOnEquityTTM": "0.362",
    "RevenueTTM": "1780700000",
    "GrossProfitTTM": "805600000",
    "DilutedEPSTTM": "3.34",
    "QuarterlyEarningsGrowthYOY": "1.161",
    "QuarterlyRevenueGrowthYOY": "0.233",
    "AnalystTargetPrice": "233.32",
    "AnalystRatingStrongBuy": "10",
    "AnalystRatingBuy": "10",
    "AnalystRatingHold": "3",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "58.82",
    "ForwardPE": "69.44",
    "PriceToSalesRatioTTM": "7.73",
    "PriceToBookRatio": "17.41",
    "EVToRevenue": "8.1",
    "EVToEBITDA": "40.41",
    "Beta": "1.154",
    "52WeekHigh": "265.69",
    "52WeekLow": "125.82",
    "50DayMovingAverage": "193.64",
    "200DayMovingAverage": "183.02",
    "SharesOutstanding": "70040000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}